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Abstract
UDP-galactosyltransferase (UDP-Gal-T) is a key enzyme in the synthesis of mucus glyco-
protein which plays an important role in gastric mucosal defensive mechanisms. Analysis of
gastric UDP-Gal-T activity should clarify the mechanisms of the action of antiulcer drugs re-
garding gastric defensive factors. Here, we examined UDP-Gal-T activity in rat gastric mucosa
treated with the antiulcer drugs geranylgeranylacetone (GGA) and cetraxate hydrochloride (CET).
The effects of coadministration of indomethacin and exogenous administration of prostaglandins
(PGs) were also studied. GGA and CET significantly increased UDP-Gal-T activity, and coad-
ministration of indomethacin inhibited the increase of enzyme activity. UDP-Gal-T activity level
with GGA was significantly higher than the control level, even in the presence of indomethacin.
With CET, however, this was not the case. Among PGs, PGE1 significantly increased enzyme
activity. Concomitant administration of PGE1 and GGA or CET increased UDP-Gal-T activity
even with indomethacin to the levels achieved when these antiulcer drugs were administered with-
out indomethacin. Our findings suggest that GGA and CET exert antiulcer effects by increasing
mucus glycoprotein synthesis and that endogenous PG synthesis may be involved in this process.
However, mechanisms not mediated by endogenous PGs may also exist in the stimulatory action
of GGA on UDP-Gal-T activity.
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